Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol

NACompletedINTERVENTIONAL
Enrollment

329

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

March 6, 2024

Study Completion Date

March 6, 2024

Conditions
Coronary Artery DiseaseMitral Valve RegurgitationMitral Valve IncompetenceHeart Failure
Interventions
DEVICE

CEP MAGNA MITRAL PERICARDIAL BIOPROSTHESES

Mitral valve replacement

Trial Locations (15)

11030

North Shore University Hospital, NY, Manhasset

11040

Long Island Jewish Medical Center, New Hyde Park

20246

University Clinica Eppendorf, Hamburg

32803

AdventHealth Orlando, Orlando

48109

University of Michigan Medical School, Ann Arbor

49503

Spectrum Health Hospitals, Grand Rapids

50266

Iowa Heart Medical Center, West Des Moines

52242

University of Iowa Hospital & Clinics, Iowa City

60611

Northwestern University Hospital, Chicago

63131

Missouri Baptist Medical Center, St Louis

95816

Dignity Health Research Institute, Sacramento

A-1130

Krankenhaus Hietzing, Vienna

V6Z 1Y6

St. Paul's Hospital, Vancouver

G1V4G5

Institut Universitaire de Cardiologie et de Pneumologie de Quebec, Québec

07740

Klinikum der Friedrich Schiller University, Jena

Sponsors
All Listed Sponsors
lead

Edwards Lifesciences

INDUSTRY